Related by context. All words. (Click for frequent words.) 78 Improves Survival 78 Clinical Trial Results 77 Patient Enrollment 77 Phase 2b Clinical Trial 77 FDA Approvals 77 Phase 2a Trial 77 Survival Benefit 77 Epilepsy Drug 77 Phase IIb Clinical Trial 76 Preclinical Data 76 Combination Treatment 76 Lupus Drug 76 Migraine Drug 76 Prolongs Survival 76 Meets Primary Endpoint 76 Neoadjuvant Chemotherapy 76 Treated Patients 75 Schizophrenia Treatment 75 First Patient Enrolled 75 Clinical Outcome 75 Cholesterol Lowering Drug 75 Statistically Significant 75 IND Filing 75 Skin Lesions 75 Phase 2b Trial 75 Data Suggest 75 Milestone Payment 75 Drug Candidate 75 Statin Drugs 75 Completes Patient Enrollment 75 Phase 1b Clinical Trial 75 Phase 2a Clinical Trial 75 Gene Linked 75 Metabolic Disorder 75 NDA Submission 75 Drug Shows Promise 75 Inhaled Insulin 75 Minimally Invasive Treatment 75 Anti Tumor Activity 74 Slow Progression 74 PDUFA Date 74 Advanced Melanoma 74 Improve Survival 74 Study Evaluating 74 Investigational Compound 74 Lung Cancer Drug 74 Adjuvant Chemotherapy 74 Initiates Clinical Trial 74 Investigational Agent 74 Present Preclinical Data 74 Phase III Trials 74 Rotavirus Vaccine 74 Anti Tumor 74 Hematological Cancers 74 Fungal Infections 74 Treating Chronic 74 Cognitive Impairment 74 Randomized Controlled Trials 74 Preclinical Study 74 Adverse Event 74 Long Term Survival 74 Gout Drug 74 Osteoarthritis Patients 74 Nicotine Vaccine 74 Submits NDA 74 Investigational Treatment 74 Psoriasis Drug 74 Recurrent Breast Cancer 74 HCV Protease Inhibitor 74 Prostate Cancer Patients 74 Pooled Analysis 73 Antitumor Activity 73 Shows Efficacy 73 Demonstrates Efficacy 73 Breast Cancer Recurrence 73 Fecal Incontinence 73 Combo Therapy 73 Randomized Trials 73 Patients Receiving 73 Prognostic Value 73 Heart Failure Patients 73 Demonstrates Significant 73 Phase III Clinical Trial 73 Osteoporosis Drug 73 Blood Pressure Drug 73 Long Term Efficacy 73 Drug Combo 73 Rheumatoid Arthritis Patients 73 Treatment Resistant 73 Confirmatory Phase 73 See CLINICAL PHARMACOLOGY 73 Phase Ib Clinical Trial 73 Treating Depression 73 Multiple Myeloma Patients 73 Lowers Risk 73 Shows Promise Against 73 Guidelines Issued 73 Statin Therapy 73 Cholesterol Drug 73 Shows Promising 73 Novel Therapies 73 Osteoporosis Treatment 73 Hepatitis C Treatment 73 Improves Outcomes 73 Vaccine Protects Against 73 Gene Variation 73 Kidney Transplant Patients 73 Systemic Delivery 73 Gene Variants 73 Kidney Function 73 Neuroprotective Effects 73 Demonstrates Potent 73 Overactive Bladder 73 Appears Safe 73 Arthritis Drug 73 Phase IIb Trial 73 Oral Fingolimod 72 Dose Escalation 72 Asthma Treatment 72 Colorectal Cancer Patients 72 Prostate Cancer Vaccine 72 Test Detects 72 Reduced Risk 72 Mouse Model 72 Lung Cancer Trial 72 Diagnostic Criteria 72 Drug Prevents 72 Proves Effective 72 Phase 2b Study 72 JAK Inhibitor 72 II Clinical Trial 72 Drug Fails 72 Estrogen Therapy 72 Genes Linked 72 Study Showed 72 Phase III Trial 72 Renal Function 72 Predict Risk 72 Immunomedics Announces 72 Showed Significant 72 Renal Cancer 72 Preclinical Models 72 Single Dose 72 Venous Thromboembolism 72 Lung Cancer Survival 72 Diabetic Neuropathy 72 Emerging Therapies 72 Successfully Completes Phase 72 Significant Reduction 72 Adjunctive Therapy 72 Genetic Markers 72 Placebo Controlled Trial 72 Testosterone Patch 72 Adjuvant Treatment 72 FDA Accepts 72 Patients Suffering 72 Combination REOLYSIN R 72 Expanded Indication 72 Genetic Tests 72 Inflammatory Markers 72 Hormone Receptor Positive 72 Pediatric Patients 72 Localized Prostate Cancer 72 Stent Thrombosis 72 Rheumatoid Arthritis Drug 72 IND Application 72 Antiplatelet Therapy 72 Osteoporosis Drugs 72 Improved Survival 72 Therapeutic Potential 72 Treatment Reduces 72 Genetic Mutation 71 Potent Antiviral Activity 71 Receives Orphan Drug Designation 71 Phase III Clinical Trials 71 Newly Diagnosed Multiple Myeloma 71 Liver Toxicity 71 Demonstrates Positive 71 Metastatic Melanoma 71 FDA Okays 71 Patients Treated With 71 Teva Provides Update 71 Hypercholesterolemia 71 Anticancer Activity 71 Pharmacokinetic Study 71 Pivotal Phase III 71 Severe Sepsis 71 Pivotal Clinical Trial 71 Cholesterol Drugs 71 Patients Undergoing 71 Disease Progression 71 Antipsychotic Drug 71 Subgroup Analysis 71 Treatment Shows Promise 71 Prognostic Factors 71 Autoimmune Disease 71 Myelodysplastic Syndromes 71 Randomized Study 71 Gastrointestinal Disorders 71 Slows Progression 71 Gene Variant 71 Study Shows Significant 71 Anticancer Drug 71 Patient Outcomes 71 Liver Failure 71 Antigen Specific 71 Demonstrates Sustained 71 Schizophrenia Drug 71 Protein Linked 71 HER2 Positive Breast Cancer 71 Therapy Improves 71 Improve Outcomes 71 Endometrial Cancer 71 Less Invasive 71 Oncology Compounds 71 Anti Clotting Drug 71 Biologic Drugs 71 Seasonal Influenza Vaccine 71 Sangamo BioSciences Announces 71 Novel Antibiotic 71 Treatment Regimen 71 Drug Coated Stents 71 Hormone Refractory Prostate Cancer 71 Therapy Shows Promise 71 Non Invasive Treatment 71 Anemia Drug 71 Cardiotoxicity 71 Long Term Outcomes 71 Gene Mutations 71 Randomized Clinical Trial 71 Diagnosis Treatment 71 Novel Oral 71 First Patient Treated 71 Inflammatory Disease 71 Pharmacyclics Announces 71 Breast Density 71 Controlled Trial 71 Genes Associated 71 Shingles Vaccine 70 Platelet Inhibition 70 AVI BioPharma Announces 70 Artery Disease 70 Acute Heart Failure 70 Meta Analysis 70 Elderly Patients 70 Diagnostic Tests 70 Clinical Evaluation 70 Stent Placement 70 Stem Cell Treatment 70 Pivotal Trial 70 Biomarker Study 70 Premature Infants 70 Breast Tumors 70 Muscle Wasting 70 Laryngeal Cancer 70 Obese Teens 70 Synthetic Peptide 70 Lung Cancers 70 Hormone Therapy 70 Significantly Improves 70 Corneal Transplant 70 Virus Linked 70 Oral Mucositis 70 Breast Cancer Treatment 70 Cancer Recurrence 70 Gastric Cancer 70 Diamyd Medical Diamyd 70 Unfractionated Heparin 70 Alternative Treatments 70 Gene Therapy Trial 70 Survival Rates 70 Obese Patients 70 Hypertensive Patients 70 Adjuvant Therapy 70 Autologous Stem Cell Transplantation 70 Genes Involved 70 Dual Antiplatelet Therapy 70 Transplant Patients 70 Nymox NX 70 Pneumococcal Vaccine 70 Fracture Risk 70 Oral Presentations 70 Surgical Procedures 70 Receives Approvable Letter 70 Key Milestones 70 Stem Cell Transplants 70 Late Breaker 70 Often Misdiagnosed 70 Septic Shock 70 Plaque Psoriasis 70 Weight Loss Drug 70 Relapsing Multiple Sclerosis 70 Antiviral Drugs 70 Fast Track Status 70 Differential Diagnosis 70 Proven Effective 70 Improve Diagnosis 70 Pulmonary Arterial Hypertension 70 Preterm Labor 70 Small Molecule 70 Effectively Treats 70 Blood Clotting 70 Therapeutic Vaccine 70 Clinical Efficacy 70 Respiratory Distress 70 Percutaneous Tibial Nerve Stimulation 70 Hepatotoxicity 70 Renal Cell Carcinoma 70 Drug Coated Stent 70 Increased Mortality 70 Low Dose 70 Brain Atrophy 70 Inflammatory Arthritis 70 Presents Preclinical Data 70 Urine Test 70 Cancer Treatments 70 Bone Metastases 70 Vaccine Adjuvant 70 Fewer Side Effects 70 Radiation Dose 70 Investigational Drug 70 Blocked Arteries 70 Carotid Stenting 70 Well Tolerated 70 Dose Ranging Study 70 Inhaled Corticosteroids 70 Transdermal Patch 70 Unmet Medical 70 Arthritis Drugs 70 Gets FDA Clearance 70 Generic Version 70 Refractory Angina 70 Interferon Beta 70 Previously Treated 70 Prospective Randomized 70 Study Shows Benefits 70 Granted Orphan Drug 70 Fabry Disease 70 Initiates Clinical 70 Cancer Vaccines 70 Brain Metastases 70 Significant Improvements 70 Experimental Vaccine 70 Subtypes 70 Premenopausal Women 70 Fibromyalgia Pain 70 Phase IIa Clinical Trial 70 Intravenous Immunoglobulin 70 Smooth Muscle 70 Treatment Naïve 70 Aromatase Inhibitors 70 Guidelines Recommend 70 Panic Disorder 69 Antipsychotic Medications 69 Chronic Lyme Disease 69 Study Demonstrates 69 Contrast Agents 69 Pivotal Study 69 Hernia Repair 69 Comorbidities 69 Reports Preclinical Data 69 Blood Pressure Drugs 69 Nuvelo Announces 69 Completes Enrollment 69 Immune Responses 69 Urinary Incontinence 69 Elevated Levels 69 Pivotal Trials 69 Knee Osteoarthritis 69 Protease Inhibitor 69 Tumor Growth 69 Brain Scans 69 Genetic Marker 69 Novel Mechanism 69 Resistant Hypertension 69 HDAC Inhibitor 69 Initiates Enrollment 69 Acne Drug 69 Kidney Transplant Recipients 69 Stent Restenosis 69 FDA Approvable Letter 69 Prostate Cancer Treatment 69 Male Contraceptive 69 FDA Clears 69 Genetic Variations 69 Levels Linked 69 Gene Mutation 69 Adverse Outcomes 69 Adenoma 69 Diabetic Nephropathy 69 Metabolic Endocrinology 69 Cardiovascular Outcomes 69 Hematological 69 Antibiotic Treatment 69 Heartburn Drugs 69 Surgical Mesh 69 Cardiovascular Disease Risk 69 Epilepsy Drugs 69 Psoriasis Patients 69 Achieves Primary Endpoint 69 Lung Cancer Patients 69 Clinical Trial Enrollment 69 Medication Errors 69 Cardiac Function 69 Vaccine Candidate 69 Orthostatic Hypotension 69 Autoimmune Diseases 69 #-# Full Text 69 Breast Cancer Cells 69 Poster Presentations 69 Survival Rate 69 Kidney Transplants 69 Cell Transplants 69 Immunologic 69 Mortality Risk 69 Risk Stratification 69 Viral Infections 69 Cervical Dysplasia 69 Genetic Mutations 69 Confirms Efficacy 69 Abstract Accepted 69 Presents Positive 69 Chemotherapy Regimen 69 Novel Inhibitor 69 Reduces Mortality 69 ANN INTERN MED 69 Generic Versions 69 Antibiotic Use 69 First Patient Dosed 69 Catheter Ablation 69 Protein Involved 69 Smallpox Vaccine 69 Advanced Prostate Cancer 69 Supplemental Biologics License Application 69 CHMP Opinion 69 Inflammatory Diseases 69 Reduces Pain 69 Genetic Screening 69 Receives Milestone Payment 69 Immunotherapeutic 69 Kidney Failure 69 Obesity Linked 69 Demonstrates Statistically Significant 69 Selective Cardiac Myosin 69 Beta Blocker 69 Anti Inflammatory Drug 69 Genetic Disorder 69 Blood Thinner 69 Cancer Stem Cells 69 Therapy Reduces 69 Receives Orphan Drug 69 Newly Diagnosed Breast Cancer 69 Tyrosine Kinase Inhibitor 69 Postmenopausal Women 69 Randomized Clinical Trials 69 Severe Acne 69 Disease Modifying 69 Study Casts Doubt 69 Antipsychotic Drugs 69 Intravenous Formulation 69 Antidepressants Linked 69 Hematopoietic Stem Cells 69 Myeloma Patients 69 Topical Treatment 69 Arch Neurol 69 Hematological Malignancies 69 Interferon Gamma 69 Hepatocellular Carcinoma 69 Sustained Reduction 69 Technological Advances 69 Antiviral Activity 69 FDA Approves Drug 69 Significant Improvement 69 Beneficial Effects 69 Symptom Relief 69 Serious Infections 69 Sleep Disturbance 69 Topline Results 69 Therapeutic Antibody 69 Renal Anemia 69 Genes Predict 69 Files IND 69 Migraine Treatment 69 Antidepressant Treatment 69 Genes Identified 69 Significantly Improved 68 Vaccine Trial 68 Lipid Levels 68 Brain Wiring 68 Package Insert 68 Chronic Sinusitis 68 Radiation Induced 68 Cardiac Resynchronization 68 Ovarian Cancer Patients 68 Newly Identified 68 Aggressive Prostate Cancer 68 Inhaled Nitric Oxide 68 Prognostic Significance 68 Metastatic Renal Cell Carcinoma 68 Colorectal Cancers 68 Initiate Clinical Trial 68 Clinical Trial Evaluating 68 Sapacitabine 68 Infected Patients 68 Mimetics 68 Aeolus Pharmaceuticals Announces 68 Anticoagulant 68 FDA Clearance 68 Metastatic Prostate Cancer 68 Early Diagnosis 68 Treatment Regimens 68 Inhaled Steroids 68 Brentuximab Vedotin SGN 68 Clostridium difficile Infection 68 Tezampanel 68 Limb Ischemia 68 Novel Small Molecule 68 Clinically Tested 68 Reduces Risk 68 Valve Replacement 68 Potentially Fatal 68 Non Responders 68 Reduce Mortality 68 Diabetic Foot Ulcer 68 Hormonal Therapy 68 Drug Eluting Stents 68 Antiplatelet 68 Aggressive Reduction 68 Sunesis Pharma 68 Oral Calcitonin 68 Commonly Used 68 Male Infertility 68 Castration Resistant Prostate Cancer 68 Total Knee Arthroplasty 68 Minimally Invasive Procedure 68 Critically Ill Patients 68 Mylan Receives Approval 68 Antitumor 68 Patients Enrolled 68 HER2 Positive 68 Ebola Vaccine 68 Heart Transplant Recipients 68 Revises FY# Outlook 68 Lupus Nephritis 68 Nasal Sprays 68 Birth Defect Risk 68 Study Evaluates 68 Fondaparinux 68 Novel Vaccine 68 Helps Predict 68 Nasdaq Deficiency Notice 68 Initiates Clinical Trials 68 Spectrum Pharmaceuticals Announces 68 Drug Resistant 68 Demonstrates Ability 68 Sleep Disturbances 68 Endovascular Treatment 68 Prostate Cancers 68 JAK2 Inhibitor 68 Glufosfamide 68 Allergic Rhinitis 68 Avian Flu Vaccine 68 Suicidality 68 Is Well Tolerated 68 Severe Asthma 68 Taro Receives 68 Announces FDA Clearance 68 Sinus Infections 68 GRAS Status 68 Employment Inducement Awards 68 Dose Response 68 Hip Fractures 68 Therapeutic Vaccines 68 Lowers Blood Pressure 68 Sipuleucel T 68 Resubmission 68 Data Indicate 68 Who Underwent 68 BioElectronics Announces 68 Excessive Sweating 68 Chronic Renal Failure 68 Bare Metal Stents 68 Patient Enrolment 68 Pregnancy Linked 68 Breast Cancer Metastasis 68 Pregnancy Outcomes 68 Node Positive 68 Immune Cell 68 Metabolic Disease 68 Help Detect 68 Benign Prostatic Hyperplasia 68 Genetic Variation 68 XPEL Announces 68 Earns Milestone Payment 68 R lenalidomide 68 Hemodialysis Patients 68 Vaccine Shows Promise 68 Prostate Tumors 68 Uterine Cancer 68 Mouse Models 68 Boosts Survival 68 Tigecycline 68 Hospitalization Rates 68 Moderate Drinking 68 Corautus Genetics 68 Stem Cell Treatments 68 Potent Anti 68 Submits Response 68 Breast Cancer Stem Cells 68 Colon Polyps 68 Metastatic Colorectal Cancer 68 Secondary Hyperparathyroidism 68 Mesothelioma Patients 68 Investigational Drugs 68 Pivotal Phase 68 Flamel Technologies Announces 68 Contrast Enhanced 68 Contrast Agent 68 Drug Approvals 68 Crit Rev 68 Chemotherapy Improves 68 Intracranial Aneurysms 68 Anticancer Drugs 68 Newly Diagnosed 68 Demonstrates Potential 68 Poniard Pharmaceuticals Announces 68 Advanced Colorectal Cancer 68 Autoimmune Disorders 68 Aethlon Medical Releases 68 RNAi Therapeutics 68 Renal Failure 68 Ovary Removal 68 Collaborators Present 68 Acute Ischemic Stroke 67 Preterm Delivery 67 Enlarged Prostate 67 Medication Adherence 67 Dose Ranging 67 Immune Cells 67 Spinal Manipulation 67 Adipose Derived Stem Cells 67 Drug Maker 67 Left Ventricular 67 Testosterone Gel 67 Oral Cavity 67 Bone Fracture 67 Going Concern Qualification 67 Outpatient Setting 67 Novel Compound 67 Protease Inhibitors 67 Relapsed Multiple Myeloma 67 Initiates Phase III 67 Retinal Diseases 67 Targeted Therapy 67 Genetic Predisposition 67 Dendritic Cells 67 Advanced Renal Cell 67 Diabetic Patients 67 Proxy Proposals 67 Novel Compounds 67 Kinase Inhibitor 67 Optimer Pharma 67 Increases Risk 67 Chronic Rhinosinusitis 67 Infarct 67 Vertebral Fractures 67 Regulatory Filing 67 Phase III Pivotal 67 Lung Injury 67 Chronic Inflammation 67 Depressive Symptoms 67 Prophylactic Treatment 67 Being Studied 67 PPD Declares 67 Clot Risk 67 Therapeutic Efficacy 67 SABCS 67 Telik Announces 67 Anticancer Agent 67 Atypical Antipsychotics 67 Stent Implantation 67 Initiates Phase II 67 Skeletal Muscle 67 Significantly Reduced 67 Molecular Mechanism 67 Hsp# Inhibitor 67 Antiangiogenic 67 Radiation Doses 67 Double Blind Placebo 67 FDA Panel Recommends 67 Effective Than 67 Cardiovasc 67 Ischemic Stroke 67 Liver Injury 67 Prolongs Life 67 Small Bowel 67 Coronary Revascularization 67 Vicriviroc 67 Hospitalized Patients 67 ST Segment Elevation 67 Menopausal Symptoms 67 Vitamin D Deficiency 67 Migraine Headache 67 Glatiramer Acetate 67 Childhood Vaccinations 67 Therapeutic Targets 67 Regimens 67 Nanophase Announces 67 ADHD Medication 67 Allergic Reactions 67 Pain Relievers 67 Signaling Pathways 67 Romiplostim 67 Angiogenic 67 Antiepileptic Drug 67 Treating Heart Failure 67 Versus Placebo 67 Circulating Tumor Cells 67 Molecular Basis 67 VIVUS Announces 67 Prospective Multicenter 67 Tumor Response 67 Progenitor Cells 67 DOR BioPharma Announces 67 Aurora Kinase 67 Antidepressant Drug 67 Cervical Spine 67 Hepatitis B Vaccine 67 Anemia Drugs 67 Safinamide 67 Lowering Blood Pressure 67 Device Helps 67 Menopausal Women 67 Completes Dosing 67 Advanced Pancreatic Cancer 67 Systemic Sclerosis 67 Double Blind Randomized 67 Peripheral Blood 67 Detecting Breast Cancer 67 Announces Poster Presentations 67 Strongly Linked 67 Genetic Testing 67 Cognitive Decline 67 Newly Diagnosed Patients 67 Acute Coronary Syndromes 67 Chronic Constipation 67 Novel Approaches 67 Heart Stents 67 Rectal Cancer 67 Erectile Dysfunction Drug 67 Heart Failure Therapy 67 MMR Vaccine 67 Cocaine Addiction 67 Diabetic Kidney Disease 67 Breast Cancer Genes 67 Imaging Technique 67 Demonstrate Significant 67 Novel Treatments 67 Drug Eluting 67 Multicenter Trial 67 Atypical Antipsychotic 67 Cholesterol Lowering Drugs 67 Lung Cancer Treatment 67 Generalized Anxiety Disorder 67 Patients Treated 67 Chemotherapy Induced 67 Chronic Hepatitis B 67 Bipolar Depression 67 Non Melanoma Skin 67 Hepatitis C Genotype 67 Pre Cancerous 67 Randomized Double Blind 67 Recombinant Human 67 Chemotherapeutic Agents 67 Radiofrequency Ablation 67 Clinical Guideline 67 Image Guided 67 Carotid Artery Stenting 67 Milestone Payment From 67 Monotherapy 67 Bipolar Mania 67 Protein Expression 67 Insulin Glargine 67 Antifungals 67 Initiates Phase 2b 67 Eye Diseases 67 Chronic Hepatitis C 67 Preclinical Evaluation 67 Study Shows Promise 67 Analytical Tool 67 Predict Dementia 67 Cholesterol Lowering 67 Glycemic Control 67 Tablet Formulation 67 RNAi Therapeutic 67 Efficacy Results 67 Licenses Novel 67 Lower Blood Pressure 67 Demonstrated Significant 67 Breast Ultrasound 67 Interferon Alfa 67 Cervical Cancer Vaccine 67 Invasive Breast Cancer 67 Coronary Artery Calcium 67 Study Reinforces 67 Tumor Targeting 67 Lung Cancer Detection 67 Dementia Risk 67 Systematic Review 67 Bone Marrow Transplants 67 Audited Financials 67 Secondary Endpoints 67 Therapeutic Antibodies 67 Vaginal Gel 67 Glaucoma Treatment 67 Antidepressant Use 67 Preliminary Findings 67 Randomized Phase II 67 Urinary Tract Infections 67 Breast Cancer Patients 67 Periodontal Disease 67 Myoblast 67 Left Ventricular Hypertrophy 67 Non Inferiority 67 Atopic Dermatitis 67 Heart Failure Treatment 67 Dose Reduction 67 Immunomodulatory 67 Stronger Warnings 67 Milestone Achieved 67 Ovarian Cancer Risk 67 Calcium Vitamin D 67 Results Confirm 67 Multiple Ascending Dose 67 Seasonal Influenza 67 Inhaled Liposomal Ciprofloxacin 67 Alvine Pharmaceuticals 67 Thromboembolic 67 TB Vaccine 66 Cognitive Deficits 66 Carotid Endarterectomy 66 Chemoradiation 66 Menopausal Hormone Therapy 66 Acute Decompensated Heart Failure 66 Antiviral Therapy 66 Stomach Cancer 66 Solid Tumors 66 Cinacalcet 66 GeoMet Announces 66 Projected Release Date 66 Clinical Outcomes 66 Viral Suppression 66 Breast Tissue 66 Breast Carcinoma 66 Unresectable 66 Drug Regimen 66 Generic Biologics 66 Hedgehog Pathway 66 Lymph Nodes 66 Myocardial Ischemia 66 Pafuramidine 66 Could Predict 66 Mammalian Cell Culture 66 Files Investigational 66 Receives Fast Track 66 Prostate Biopsy 66 Presents Preclinical 66 Cognitive Function 66 Novel Protein 66 Peripheral Arterial 66 Artificial Pancreas 66 Announcement acc 66 Helps Identify 66 Oral Laquinimod 66 Patent Covering 66 Mitochondrial Dysfunction 66 Ovarian Cancers 66 Collaborators Publish 66 Prevent Breast Cancer 66 Clinical Study Shows 66 Obstet Gynecol 66 Peptic Ulcer 66 Milestone Payments 66 Plus Ribavirin 66 Stereotaxis Announces 66 BioSante Pharmaceuticals Reports 66 Aneurysm Repair 66 Microfluidic Device 66 Refractory Hodgkin Lymphoma 66 Migraine Pain 66 Patient Treated 66 Orphan Diseases 66 Migraine Headaches 66 Announce Collaboration Agreement 66 Bone Mineral Density 66 TriCo Bancshares Announces 66 Effective Treatments 66 Abdominal Fat 66 Imaging Techniques 66 Insulin Sensitivity 66 Eur J 66 Liprotamase 66 Oral Cladribine 66 Oral Insulin 66 Anthracycline 66 Treatment Naive Patients 66 Expedited Review 66 Poster Discussion 66 Study Validates 66 Embolic Protection 66 CT Angiography 66 Tuberculosis Vaccine 66 Novel Method 66 Identifies Potential 66 Blood Thinners 66 Cardiovascular Events 66 Calcium Supplements 66 ASCO GI 66 EastGroup Properties Announces 66 Antibiotic Resistant 66 FY# EPS View 66 Helps Detect 66 PET Scans 66 Weight Loss Supplement 66 Shown Effective 66 Liver Metastases 66 J Am Coll 66 Nerve Regeneration 66 Cholesterol Levels 66 Lymphoma Patients 66 Treat Anemia 66 Cognitive Problems 66 Venous Thrombosis 66 Low Incidence 66 Anti CD# Antibody 66 Advanced Ovarian Cancer 66 Adverse Effects 66 Antifungal 66 Bacterial Infection 66 Generic Version Of 66 Consulting Fees Honoraria 66 Screening Mammography 66 Trial Halted 66 Pulmonary Artery 66 Protein Biomarker 66 Diabetic Neuropathic Pain 66 Stakeholder Opinions 66 TNF Blockers 66 Trial Evaluating 66 Sustained Release 66 Metastatic Cancer 66 Chronic Myeloid Leukemia 66 Insulin Pen 66 Breast Cancers 66 Controlled Study 66 Blood Glucose Testing 66 Polymerase Inhibitor 66 Receives Complete Response 66 Cancer Biomarkers 66 Receives CE Marking 66 Node Negative 66 Breast Tumor 66 Commercialize Novel 66 Chronic Heart Failure 66 Bare Metal Stent 66 Ovarian Cancer Treatment 66 Liver Tumors 66 Develop Novel 66 Regeneron Pharma 66 Genital Herpes 66 Prostate Cancer Progression 66 Mycophenolate Mofetil 66 Wound Closure 66 Preclinical Efficacy 66 Unstable Angina 66 Hepatic Encephalopathy 66 Prolonged Survival 66 Guideline Update 66 Receives SFDA Approval 66 Muscle Function 66 Adult Stem Cell Therapy 66 J Clin 66 Multicenter Phase 66 FY# Guidance 66 Psychiatric Disorders 66 Trigeminal Neuralgia 66 Preterm Infants 66 Pancreatic Islet 66 LibiGel ® 66 Content Outline 66 Chronic Wounds 66 Functional Outcomes 66 Attenuates 66 Hormone Replacement 66 Colorectal Adenomas 66 Randomized Phase 66 Receive Milestone Payment 66 Uterine Fibroid Embolization 66 Ischemic